跳至主要内容
临床试验/ISRCTN54865992
ISRCTN54865992已完成未知

mHealth for the early diagnosis and effective treatment of cutaneous leishmaniasis: a randomized trial comparing the completeness of assessment of adverse events and therapeutic outcome in those whose follow-up is supported by eHealth, versus standard of care, in parasitologically confirmed cases

Centro Internacional de Entrenamiento e Investigaciones Medicas0 个研究点目标入组 104 人开始时间: 2021年10月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
104

研究概览

简要总结

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36972285/ results (added 28/03/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Residence in one of the three veredas (townships) previously identified as:
  • 1.1. Having a relatively high incidence of CL in the Colombia National System of Public Health Surveillance (SIVIGILA)
  • 1.2. Safe to work
  • 1.3. Relatively accessible
  • 2. At least one cutaneous lesion

排除标准

  • 1. Mucosal leishmaniasis
  • 2. Contraindication to receive treatment in the area of residence, i.e. with condition which requires treatment in the IPS

研究者

发起方
Centro Internacional de Entrenamiento e Investigaciones Medicas

相似试验